Based on these results, two phase 3 trials are being planned for platinum - sensitive and platinum -
resistant ovarian cancer patients by one of NCI's new National Cancer Trial Network Groups, the NRG Oncology Group (formerly 3 cooperative groups: the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG).
Not exact matches
When
patients with advanced
ovarian cancer become
resistant to one drug, clinicians usually prescribe a new drug.
The study evaluated 56
patients with
ovarian clear cell adenocarcinoma (CCA), an aggressive form of
ovarian cancer that is more likely to be
resistant to chemotherapy and to have a poorer prognosis than other forms of this disease.
«Once the
ovarian cancer becomes drug resistant we can not cure it,» says Rodriguez a gynecologic oncologist who provides treatment to ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New J
cancer becomes drug
resistant we can not cure it,» says Rodriguez a gynecologic oncologist who provides treatment to
ovarian cancer patients and is director of the precision medicine initiative at Rutgers Cancer Institute of New J
cancer patients and is director of the precision medicine initiative at Rutgers
Cancer Institute of New J
Cancer Institute of New Jersey.
Most
patients diagnosed with advanced
ovarian cancer develop platinum
resistant / refractory disease.